Search research articles
Contact Us
Filters
Showing results (181-190 of 357) with videos related to
Page
of 36
Sort By:
Cardiovascular Drugs and Therapy
|
August 1, 1995
Digoxin and mortality in survivors of acute myocardial infarction: observations in patients at low and intermediate risk. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial
J Leor, U Goldbourt, S Behar, et al.
Currents in Pharmacy Teaching & Learning
|
July 21, 2018
Pharmacy resident teaching and learning curriculum program outcomes: Student performance and quality assessment
Michelle Z Farland, Xiaoying Feng, Andrea S Franks, et al.
Circulation
|
December 1, 1979
Survival in medically treated coronary artery disease
P J Harris, F E Harrell, K L Lee, et al.
Harefuah
|
January 1, 1981
[Return to work after acute myocardial infarction]
S Behar, E Cohen, M Wolyvovics, et al.
Journal of Clinical Epidemiology
|
October 1, 1995
The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial
E Disegni, U Goldbourt, H Reicher-Reiss, et al.
Cardiovascular Drugs and Therapy
|
October 1, 1995
Digoxin and increased mortality among patients recovering from acute myocardial infarction: importance of digoxin dose. The SPRINT Study Group
J Leor, U Goldbourt, B Rabinowitz, et al.
Cellular Immunology
|
April 15, 1986
The role of monoclonal antibodies and the recombinant DNA technology in studying autoantibody production
M D Scharff, R A DePinho, S Behar, et al.
The American Journal of Cardiology
|
June 30, 1998
Effect of beta-blocker therapy in patients with coronary artery disease in New York Heart Association classes II and III. The Bezafibrate Infarction Prevention (BIP) Study Group
M Haim, A Shotan, V Boyko, et al.
Journal of the American College of Cardiology
|
April 3, 1998
Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group
S Braun, V Boyko, S Behar, et al.
The American Journal of Medicine
|
April 1, 1993
Circadian variation and possible external triggers of onset of myocardial infarction. SPRINT Study Group
S Behar, M Halabi, H Reicher-Reiss, et al.
Page
of 36
Search research articles
Search
Showing results (181-190 of 357) with videos related to
Sort By:
Page
of 36
Cardiovascular Drugs and Therapy
|
August 1, 1995
Digoxin and mortality in survivors of acute myocardial infarction: observations in patients at low and intermediate risk. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial
J Leor, U Goldbourt, S Behar, et al.
Currents in Pharmacy Teaching & Learning
|
July 21, 2018
Pharmacy resident teaching and learning curriculum program outcomes: Student performance and quality assessment
Michelle Z Farland, Xiaoying Feng, Andrea S Franks, et al.
Circulation
|
December 1, 1979
Survival in medically treated coronary artery disease
P J Harris, F E Harrell, K L Lee, et al.
Harefuah
|
January 1, 1981
[Return to work after acute myocardial infarction]
S Behar, E Cohen, M Wolyvovics, et al.
Journal of Clinical Epidemiology
|
October 1, 1995
The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial
E Disegni, U Goldbourt, H Reicher-Reiss, et al.
Cardiovascular Drugs and Therapy
|
October 1, 1995
Digoxin and increased mortality among patients recovering from acute myocardial infarction: importance of digoxin dose. The SPRINT Study Group
J Leor, U Goldbourt, B Rabinowitz, et al.
Cellular Immunology
|
April 15, 1986
The role of monoclonal antibodies and the recombinant DNA technology in studying autoantibody production
M D Scharff, R A DePinho, S Behar, et al.
The American Journal of Cardiology
|
June 30, 1998
Effect of beta-blocker therapy in patients with coronary artery disease in New York Heart Association classes II and III. The Bezafibrate Infarction Prevention (BIP) Study Group
M Haim, A Shotan, V Boyko, et al.
Journal of the American College of Cardiology
|
April 3, 1998
Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group
S Braun, V Boyko, S Behar, et al.
The American Journal of Medicine
|
April 1, 1993
Circadian variation and possible external triggers of onset of myocardial infarction. SPRINT Study Group
S Behar, M Halabi, H Reicher-Reiss, et al.
Page
of 36